130 results on '"Pain, Postoperative prevention & control"'
Search Results
2. A Peer Data Benchmarking Intervention to Reduce Opioid Overprescribing: A Randomized Controlled Trial.
- Author
-
Dun C, Overton HN, Walsh CM, Hennayake S, Wang P, Fahim C, Bicket MC, and Makary MA
- Subjects
- Aged, Humans, United States, Benchmarking, Inappropriate Prescribing, Practice Patterns, Physicians', Medicare, Analgesics, Opioid therapeutic use, Pain, Postoperative drug therapy, Pain, Postoperative prevention & control
- Abstract
Background: Driving physician behavior change has been an elusive goal for quality improvement efforts aimed at reducing low-value care. We proposed the use of "nudge" interventions at the surgeon level in order to reduce post-surgical opioid overprescribing in accordance with consensus guidelines., Methods: We used 2017 Medicare data to identify outlier surgeons. A peer data benchmarking report that showed each surgeon the average number of opioid tablets they prescribed for an open inguinal hernia repair procedure from January 1, 2017 to December 31, 2017. We conducted a 1:1 randomized controlled trial providing outlier surgeons a report of their opioid prescribing patterns for a standard operation compared to the national average and prescribing guidelines., Results: There were 489 surgeons randomized to the intervention, of which 180 (36.8%) had data in the post-intervention period. Data was available for 87 surgeons in the intervention group and 93 surgeons in the control group. 97.7% of surgeons in the intervention group reduced their opioid prescribing pattern compared to 95.7% in the control group. Surgeons who received the data benchmarking report intervention prescribed 14.3% less opioids than surgeons in the control group (10.54 (SD 5.34) vs. 12.30 (SD 6.02), P = .04). The intervention was associated with a 1.83 lower mean number of opioid tablets prescribed per patient in the multivariable linear regression model after controlling for other factors (Intervention group vs. control group 95% CI [-3.61, -.04], P = .04)., Discussion: The implementation of a peer data benchmarking intervention can drive physician behavior change towards high-value care., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2023
- Full Text
- View/download PDF
3. Total joint replacement in ambulatory surgery.
- Author
-
Baratta JL, Deiling B, Hassan YR, and Schwenk ES
- Subjects
- Humans, Aged, United States, Ambulatory Surgical Procedures, Pain, Postoperative diagnosis, Pain, Postoperative prevention & control, Medicare, Postoperative Nausea and Vomiting, Anesthesia, Conduction, Arthroplasty, Replacement, Knee adverse effects, Arthroplasty, Replacement, Knee methods, Arthroplasty, Replacement, Hip
- Abstract
Total joint arthroplasty is one of the most commonly performed surgical procedures in the United States, and projected numbers are expected to double in the next ten years. From 2018 to 2020, total hip and knee arthroplasty were removed from the United States' Center for Medicare and Medicaid Services "inpatient-only" list, accelerating this migration to the ambulatory setting. Appropriate patient selection, including age, body mass index, comorbidities, and adequate social support, is critical for successful ambulatory total joint arthroplasty. General anesthesia and neuraxial anesthesia are both safe and effective anesthetic choices, and recent studies in this population have found no difference in outcomes. Multimodal analgesia, including acetaminophen, nonsteroidal anti-inflammatory drugs, local infiltration analgesia, and peripheral nerve blocks, is the foundation for adequate pain control. Common reasons for "failure to launch" include postoperative urinary retention, postoperative nausea and vomiting, inadequate analgesia, and hypotension., (Copyright © 2023 Elsevier Ltd. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
4. Evidence-based perioperative opioid-sparing techniques during the United States opioid crisis.
- Author
-
Warinner C, Parker LF, Shapiro F, and Jowett N
- Subjects
- Humans, United States, Pain, Postoperative drug therapy, Pain, Postoperative prevention & control, Pain Management methods, Anti-Inflammatory Agents, Non-Steroidal, Analgesics, Opioid therapeutic use, Opioid Epidemic prevention & control
- Abstract
Purpose of Review: The current United States opioid epidemic resulted from the overprescribing of opioids by physicians and surgeons in response to deceptive and unlawful marketing campaigns by pharmaceutical companies seeking to profit from opioid sales. Surgeons have a moral obligation to employ evidence-based opioid-sparing analgesia protocols for management of perioperative pain., Recent Findings: Recent evidence strongly supports the use of NSAIDs in perioperative pain management, with large studies demonstrating no increased risk of postoperative hemorrhage or renal insult., Summary: We present an evidence-based approach for opioid-sparing perioperative pain management, including multimodal analgesia guidelines used at our center for patients undergoing free flap facial reanimation procedures., (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
5. A Qualitative Examination of Opioid Sparing Anesthesia Practices Among CRNAs.
- Author
-
Knell SL, Marks LE, Sauri A, and Simonovich SD
- Subjects
- Humans, United States, Nurse Anesthetists, Pain Management, Pain, Pain, Postoperative drug therapy, Pain, Postoperative prevention & control, Analgesics, Opioid, Anesthesia
- Abstract
Purpose: The purpose of this study was to examine the experiences of CRNAs using opioid sparing techniques in their perioperative anesthesia practice., Design: This study used a qualitative descriptive methodology., Methods: Semistructured individual interviews were conducted with Certified Registered Nurse Anesthetists who use opioid sparing anesthesia in their clinical practice in the United States., Findings: Sixteen interviews were completed. Thematic network analysis revealed two major themes: (1) perioperative benefits of opioid sparing anesthesia and (2) prospective benefits of opioid sparing anesthesia. Perioperative benefits described include reduction or elimination of postoperative nausea and vomiting, superior pain control, and improved short-term recovery. Prospective benefits described include higher surgeon satisfaction, superior surgeon-managed pain control, increased patient satisfaction, reduction of opioids in the community, and awareness of positive prospective benefits of opioid sparing anesthesia., Conclusions: This study highlights the significance of opioid sparing anesthesia and its role in comprehensive perioperative pain control, reduction of opioids in the community, and patient recovery beyond the postanesthesia care unit., (Copyright © 2022 American Society of PeriAnesthesia Nurses. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
6. Updated Centers for Disease Control and Prevention Guidelines on Opioid Prescribing: What Should Surgeons Know?
- Author
-
Cramer JD, Anne S, and Brenner MJ
- Subjects
- United States, Humans, Analgesics, Opioid therapeutic use, Practice Patterns, Physicians', Centers for Disease Control and Prevention, U.S., Pain, Postoperative drug therapy, Pain, Postoperative prevention & control, Chronic Pain drug therapy, Chronic Pain prevention & control, Surgeons
- Abstract
The Centers for Disease Control and Prevention (CDC) recently published a 2022 guideline on opioid prescribing for acute, subacute, and chronic pain. This information is relevant to surgeons because many patients receive their first opioid prescription after surgery. When prescribing opioids, surgeons walk the line between benefit and harm. Many of the CDC recommendations mirror the AAO-HNS Clinical Practice Guideline: Opioid Prescribing for Analgesia After Common Otolaryngology Operations. For example, opioids are not recommended as first-line therapy for acute pain from otolaryngology-head, and neck surgery procedures. New insights include safeguards and strategies to mitigate the risk of complications in patients with chronic pain undergoing surgical procedures. Consultation with a pain specialist should be considered for patients transitioning from acute to chronic pain, cognizant of the risks of abrupt discontinuation of opioids in patients with opioid use disorder. This article summarizes key considerations for providing individualized, evidence-based perioperative pain management., (© 2023 American Academy of Otolaryngology-Head and Neck Surgery Foundation.)
- Published
- 2023
- Full Text
- View/download PDF
7. Perioperative opioid management for minimally invasive hysterectomy.
- Author
-
Madsen AM, Martin JM, Linder BJ, and Gebhart JB
- Subjects
- Female, Humans, United States, Pain, Postoperative drug therapy, Pain, Postoperative prevention & control, Pain, Postoperative etiology, Practice Patterns, Physicians', Hysterectomy adverse effects, Hysterectomy methods, Analgesics, Opioid therapeutic use, Opioid-Related Disorders prevention & control, Opioid-Related Disorders complications, Opioid-Related Disorders drug therapy
- Abstract
Given the high volume of hysterectomies performed, the contribution of gynecologists to the opioid crisis is potentially significant. Following a hysterectomy, most patients are over-prescribed opioids, are vulnerable to developing new persistent opioid use, and can be the source of misuse, diversion, or accidental exposure. People who misuse opioids are at risk of an overdose related death, which is now one of the leading causes of death in the United States and is rising in other countries. It is the physician's responsibility to reduce opioid use by making impactful practice changes, such as 1) using pre-emptive opioid sparing strategies, 2) optimizing multimodal nonopioid pain management, 3) restricting postoperative opioid prescribing, and 4) educating patients on proper disposal of unused opioids. These changes can be implemented with an enhanced recovery after surgery protocol, shared decision-making, and patient education strategies related to opioids., Competing Interests: Declaration of competing interest Annetta M. Madsen, MD: NoneJessica M. Martin, DO: None Brian J. Linder, MD, MS: None John B. Gebhart, MD, MS: UroCure – advisory board; UpToDate – royalties; Elsevier - royalties., (Copyright © 2022. Published by Elsevier Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
8. Anesthetic and analgesic techniques used for dogs undergoing ovariohysterectomies in general practice in the United States.
- Author
-
Kramer BM, Hellyer PW, Rishniw M, and Kogan LR
- Subjects
- Female, Dogs, United States, Animals, Cross-Sectional Studies, Analgesics therapeutic use, Hysterectomy veterinary, Pain drug therapy, Pain veterinary, Anesthetics, Local therapeutic use, Anti-Inflammatory Agents, Non-Steroidal therapeutic use, Pain, Postoperative prevention & control, Pain, Postoperative veterinary, Pain, Postoperative drug therapy, Ovariectomy veterinary, Anesthesia veterinary, Anesthesia methods, General Practice, Dog Diseases drug therapy
- Abstract
Objective: To acquire information about anesthesia and analgesia protocols used by United States (US) veterinarians in primary care practices when performing routine ovariohysterectomy in dogs., Study Design: Cross-sectional survey., Population: Primary care veterinarians in the US., Methods: An online anonymous survey, originally created in New Zealand, was modified with permission and made available to Veterinary Information Network (VIN) members. The survey asked questions about performing ovariohysterectomy in healthy adolescent dogs in the categories of preanesthetic evaluation, premedication and induction protocols, maintenance protocols and monitoring equipment, and postoperative analgesic and sedation protocols and pain assessments., Results: A total of 1213 US veterinarians completed the survey. Respondents (n; %) reported performing preoperative laboratory tests [packed cell volume (135; 11%), complete blood cell count (889; 73%) and biochemistry panels (1057; 87%)] and preanesthetic examinations on the morning of surgery (1083; 90%). The most commonly administered drugs for premedication were acepromazine (512; 42%), hydromorphone (475; 39%) or butorphanol (463; 38%), with propofol (637; 67%) for induction of anesthesia and isoflurane (882; 73%) for maintenance of anesthesia. Most veterinarians reported placing intravenous catheters (945; 78%), administering electrolyte solutions (747; 67%) and providing heat support (1160; 96%). Perioperative and postoperative analgesia included local anesthetics (545; 45%), opioids (844; 70%) and non-steroidal anti-inflammatory drugs (NSAIDs) (953; 79%); NSAIDs were dispensed for home use (985; 81%). Dogs were most frequently discharged on the day of surgery (1068; 88%) and the owners were contacted (914; 75%) for follow-up within 1-2 days., Conclusions and Clinical Relevance: Anesthetic management for routine ovariohysterectomy in dogs varies among US veterinary VIN members. Information from this study is useful for all veterinarians for comparison with their practice management and for teachers of veterinary anesthesia to continue to emphasize options for analgesia., (Copyright © 2022 Association of Veterinary Anaesthetists and American College of Veterinary Anesthesia and Analgesia. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
9. Periarticular Injection in Total Joint Arthroplasty: The Clinical Practice Guidelines of the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, Hip Society, and Knee Society.
- Author
-
Hannon CP, Fillingham YA, Spangehl MJ, Karas V, Kamath AF, Hamilton WG, and Della Valle CJ
- Subjects
- Arthroplasty, Humans, Injections, Intra-Articular, Pain, Pain, Postoperative drug therapy, Pain, Postoperative etiology, Pain, Postoperative prevention & control, United States, Anesthesia, Conduction, Arthroplasty, Replacement, Hip, Orthopedic Surgeons
- Published
- 2022
- Full Text
- View/download PDF
10. Impact of Opioid Restriction Legislation on Prescribing Practices for Outpatient Plastic and Reconstructive Surgery.
- Author
-
O'Brien AL, Krasniak PJ, Schroeder MJ, Desai MN, Diaz A, and Chetta MD
- Subjects
- Drug Prescriptions, Humans, Morphine Derivatives, Outpatients, Pain, Postoperative drug therapy, Pain, Postoperative epidemiology, Pain, Postoperative prevention & control, Practice Patterns, Physicians', Retrospective Studies, United States, Analgesics, Opioid therapeutic use, Plastic Surgery Procedures
- Abstract
Background: Overprescription of opioids for acute postoperative pain, plastic surgery procedures included, is contributing to the pervasive opioid epidemic in the United States. This study examines the effect of a statewide legislation limiting postoperative opioids on opioid prescription behavior among providers following outpatient plastic surgery procedures at a high-volume academic center., Methods: Retrospective review of all outpatient surgical encounters between June 1, 2016, and November 30, 2018, was performed. Encounters were grouped into two cohorts: prepolicy and postpolicy. Primary outcomes included total oral morphine equivalents prescribed on the day of surgery and proportion of patients prescribed greater than 210 oral morphine equivalents. Secondary outcomes included proportion of patients requiring an opioid refill within 30 days following surgery, and number of refills required., Results: The mean oral morphine equivalents prescribed on the day of surgery was reduced from 271.8 to 150.37 oral morphine equivalents ( p < 0.001) following implementation of the legislation, with an associated decrease in the standard deviation of oral morphine equivalents prescribed from 225.35 to 196.71 ( p < 0.001), suggesting a decrease in the variability of prescriber practices. Time series analysis demonstrated the decrease in oral morphine equivalents remained significant when accounting for baseline level of change in opioid prescription patterns., Conclusion: This study provides evidence that legislation at the state level restricting postoperative opioid prescriptions is associated with a decrease in opioid prescriptions without an increase in the need for refills in the acute postoperative setting following outpatient plastic surgery procedures., (Copyright © 2022 by the American Society of Plastic Surgeons.)
- Published
- 2022
- Full Text
- View/download PDF
11. Opioid Prescribing Practices Among Plastic Surgeons: Results of the 2019 American Society of Plastic Surgeons Opioid Survey.
- Author
-
Oberhofer HM, Rao A, Carlson JT, Mast BA, Simmons CJ, Gutowski KA, and Satteson ES
- Subjects
- Analgesics, Opioid therapeutic use, Anesthetics, Local, Humans, Pain, Postoperative drug therapy, Pain, Postoperative prevention & control, Practice Patterns, Physicians', Surveys and Questionnaires, United States, Mammaplasty, Surgeons
- Abstract
Background: Health care providers play an important role in the national opioid crisis with 40% of opioid-related deaths being attributed to prescription medications (Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. 2018) and as many as half of the opioid pills prescribed after outpatient plastic surgery may go unused (Plast Reconstr Surg 2019;143:929-938). The purpose of this study was to provide broad foundational data regarding postoperative analgesic prescribing patterns among members of the American Society of Plastic Surgeons (ASPS) to facilitate inclusion of opioid data fields in the ASPS Tracking Operations and Outcomes for Plastic Surgeons database for longitudinal evaluation., Methods: A survey regarding opioid prescribing practices was electronically distributed to a representative cohort of 2555 ASPS members. Two hundred seventy-nine responses (11% response rate) were received., Results: The majority of respondents reported prescribing opioids following 1 or more types of cosmetic and reconstructive procedures (90.2% and 81.7%, respectively; p = 0.0057), most commonly oxycodone and hydrocodone. Most (61.9%) reported less than 5% of patients request an opioid refill. Nonopioid medications, most commonly acetaminophen and ibuprofen/naproxen, were also prescribed but less commonly so for cosmetic (80.7-85.8%) than reconstructive (86.3-91.5%) procedures. Local anesthetic was less commonly used for mastopexy (83.7%) than augmentation (91.8%, p = 0.02)., Conclusions: Based on survey responses, potential areas of improvement to reduce opioid prescribing and use include provider education on the use of multimodal pain regimens including nonopioid medication and "as needed" rather than scheduled dosing, use of local anesthetic blocks, as well as patient education on opioid safety and proper disposal of unused medication., Competing Interests: Conflicts of interest and sources of funding: none declared., (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
12. Opioid prescribing practices at hospital discharge for surgical patients before and after the Centers for Disease Control and Prevention's 2016 opioid prescribing guideline.
- Author
-
Langnas E, Bishara A, Croci R, Rodriguez-Monguio R, Wick EC, Chen CL, and Guan Z
- Subjects
- Adult, Centers for Disease Control and Prevention, U.S., Hospitals, Humans, Pain, Postoperative drug therapy, Pain, Postoperative prevention & control, Practice Patterns, Physicians', United States epidemiology, Analgesics, Opioid therapeutic use, Patient Discharge
- Abstract
Background: The Centers for Disease Control and Prevention's (CDC) March 2016 opioid prescribing guideline did not include prescribing recommendations for surgical pain. Although opioid over-prescription for surgical patients has been well-documented, the potential effects of the CDC guideline on providers' opioid prescribing practices for surgical patients in the United States remains unclear., Methods: We conducted an interrupted time series analysis (ITSA) of 37,009 opioid-naïve adult patients undergoing inpatient surgery from 2013-2019 at an academic medical center. We assessed quarterly changes in the discharge opioid prescription days' supply, daily and total doses in oral morphine milligram equivalents (OME), and the proportion of patients requiring opioid refills within 30 days of discharge., Results: The discharge opioid prescription declined by -0.021 (95% CI, -0.045 to 0.003) days per quarter pre-guideline versus -0.201 (95% CI, -0.223 to -0.179) days per quarter post-guideline (p < 0.0001). Likewise, the mean daily and total doses of the discharge opioid prescription declined by -0.387 (95% CI, -0.661 to -0.112) and -7.124 (95% CI, -9.287 to -4.962) OME per quarter pre-guideline versus -2.307 (95% CI, -2.560 to -2.055) and -20.68 (95% CI, -22.66 to -18.69) OME per quarter post-guideline, respectively (p < 0.0001). Opioid refill prescription rates remained unchanged from baseline., Conclusions: The release of the CDC opioid guideline was associated with a significant reduction in discharge opioid prescriptions without a concomitant increase in the proportion of surgical patients requiring refills within 30 days. The mean prescription for opioid-naïve surgical patients decreased to less than 3 days' supply and less than 50 OME per day by 2019., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
13. Postoperative pain and opioid use after breast reduction with or without preoperative nerve block.
- Author
-
LaFontaine SN, Yao A, Hwang LK, Draper L, Benacquista T, Garfein ES, and Weichman KE
- Subjects
- Analgesics, Opioid therapeutic use, Humans, Morphine, Pain, Postoperative drug therapy, Pain, Postoperative prevention & control, Prospective Studies, Quality of Life, United States, Mammaplasty, Nerve Block methods, Opioid-Related Disorders
- Abstract
Background: Physician-prescribed opioids have been implicated as key contributing factors in the current opioid epidemic in the United States. Breast reduction mammoplasty is one of the most commonly performed procedures in plastic surgery and patients are often prescribed large amounts of postoperative opioids. Here we investigate the effects of erector spinae nerve blocks on postoperative pain, opioid consumption, and quality of life after breast reduction., Methods: Following the institutional review board (IRB) approval, a prospective cohort study of some patients undergoing breast reduction mammoplasty at Montefiore Medical Center between June and September 2019 was undertaken. The patients were stratified into two cohorts for further analysis: those who received preoperative erector spinae nerve block and those who did not. Primary outcomes measures analyzed included Likert pain scores, patient-reported outcome measures, and opioid consumption for the first five postoperative days., Results: Forty-seven patients were enrolled in the analysis. Thirteen patients (28%) received nerve blocks, 34 (72%) did not. On average, the patients were prescribed 114.3 (±34.6) morphine equivalents postoperatively and they consumed 45% (±35.3) by the end of the first five days post-surgery. There were no significant differences between cohorts in morphine equivalents prescribed or consumed, postoperative pain scores, or patient-reported outcome measures., Conclusions: Following breast reduction mammoplasty, patients on average consumed < 50% of prescribed opioids, suggesting over-prescription of postoperative opioids for breast reduction recovery. Preoperative nerve block did not improve pain scores or decrease opioid consumption for the first five days after surgery., (Copyright © 2021 Elsevier Ltd. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
14. Prospective Randomized Study Examining Preoperative Opioid Counseling on Postoperative Opioid Consumption after Upper Extremity Surgery.
- Author
-
Vincent S, Paskey T, Critchlow E, Mann E, Chapman T, Abboudi J, Jones C, Kirkpatrick W, Namdari S, Hammoud S, and Ilyas AM
- Subjects
- Counseling, Humans, Prospective Studies, United States, Upper Extremity surgery, Analgesics, Opioid therapeutic use, Pain, Postoperative drug therapy, Pain, Postoperative prevention & control
- Abstract
Background: Rates of opioid addiction and overdose continue to climb in the United States, increasing pressure on prescribers to identify solutions to decrease postoperative opioid consumption. Hand and upper extremity surgeries are high-volume surgeries with a predilection for inadvertent overprescribing. Recent investigations have shown that preoperative opioid counseling may decrease postoperative opioid consumption. In order to test this hypothesis, a prospective randomized trial was undertaken to determine the effect of preoperative opioid counseling on postoperative opioid consumption. Methods: Eligible patients undergoing outpatient upper extremity surgery were randomized to either receive preoperative opioid counseling or to receive no counseling. Surgeons were blinded to their patient's counseling status. Preoperatively, patient demographics, surgical and prescription details were recorded. Postoperatively, patients' pain experience including opioid consumption, pain levels, and satisfaction was recorded. Results: There were 131 total patients enrolled, with 62 in the counseling group and 69 in the control group. Patients receiving counseling consumed 11.8 pills compared to 17.4 pills in the control group ( P = .007), which translated to 93.7 Morphine Equivalent Units (MEU) in the counseling group compared to 143.2 MEU in the control group ( P = .01). There was no difference in pain scores at any time point between groups. Among all study patients a total of 3767 opioid pills were prescribed with approximately 50% left unused. Conclusion: Patients receiving preoperative counseling consumed significantly fewer opioids postoperatively. Inadvertant overprescribing remains high. Routine use of preoperative counseling should be implemented along with prescribing fewer opioids overall to prevent overprescribing.
- Published
- 2022
- Full Text
- View/download PDF
15. National and State Level Opioid-Restricting Legislation in Total Joint Arthroplasty: A Systematic Review.
- Author
-
Randall DJ, Vanood A, Jee Y, and Moore DD
- Subjects
- Arthroplasty, Humans, Pain Management, Pain, Postoperative drug therapy, Pain, Postoperative epidemiology, Pain, Postoperative prevention & control, Practice Patterns, Physicians', Retrospective Studies, United States epidemiology, Analgesics, Opioid therapeutic use, Opioid-Related Disorders epidemiology, Opioid-Related Disorders prevention & control
- Abstract
Background: The opioid epidemic is a health crisis in the United States. Within orthopedic surgery, opioid misuse and incautious prescription remains a concern. In the last several years, there has been a growing interest and public effort toward reducing opioid use in total joint arthroplasty (TJA) in response to the opioid epidemic in the United States. We aim to review opioid-limiting practices, policies, and legislations that are implemented at the state level and nationally that are relevant to TJA, as well as evaluate studies that measure the efficacy of these policies in the management of patients undergoing TJA., Methods: Two independent reviewers conducted a systematic review of national and state level opioid-limiting policies implemented in the United States and their effects on opioid prescription, in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement (PRISMA)., Results: We identified 3 national bills and 9 policies set forth by national organizations that imposed limits on opioid prescription. Opioid-reducing legislation was also identified in 24 states, with the majority specifying a 7-day limit on initial opioid prescription for acute pain management. Six research studies evaluating the impact of opioid-restricting policies on postoperative opioid prescription for TJA patients were found. Three studies assessed legislation at the state level while the others were institution-based guidelines. Overall, these studies demonstrated a significant decrease in mean morphine milligram equivalents of initial opioid prescription after implementing the policies., Conclusion: Recent opioid-restricting legislation is effective in decreasing postoperative opioid prescriptions following TJA., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
16. Preoperative Opioid Use and Readmissions Following Surgery.
- Author
-
Tang R, Santosa KB, Vu JV, Lin LA, Lai YL, Englesbe MJ, Brummett CM, and Waljee JF
- Subjects
- Aged, Aged, 80 and over, Drug Prescriptions statistics & numerical data, Female, Humans, Incidence, Male, Pain, Postoperative epidemiology, Postoperative Period, Retrospective Studies, Risk Factors, United States epidemiology, Analgesics, Opioid therapeutic use, Pain, Postoperative prevention & control, Patient Readmission trends, Preoperative Care methods
- Abstract
Objective: To assess the association between preoperative opioid exposure and readmissions following common surgery., Summary Background Data: Preoperative opioid use is common, but its effect on opioid-related, pain-related, respiratory-related, and all-cause readmissions following surgery is unknown., Methods: We analyzed claims data from a 20% national Medicare sample of patients ages ≥ 65 with Medicare Part D claims undergoing surgery between January 1, 2009 and November 30, 2016. We grouped patients by the dose, duration, recency, and continuity of preoperative opioid prescription fills. We used logistic regression to examine the association between prior opioid exposure and 30-day readmissions, adjusted for patient risk factors and procedure type., Results: Of 373,991 patients, 168,579 (45%) filled a preoperative opioid prescription within 12 months of surgery, ranging from minimal to chronic high use. Preoperative opioid exposure was associated with higher rate of opioid-related readmissions, compared with naive patients [low: aOR=1.63, 95% CI=1.26-2.12; high: aOR=3.70, 95% CI=2.71-5.04]. Preoperative opioid exposure was also associated with higher risk of pain-related readmissions [low: aOR=1.27, 95% CI=1.23-1.32; high: aOR=1.62, 95% CI=1.53-1.71] and respiratory-related readmissions [low: aOR=1.10, 95% CI=1.05-1.16; high: aOR=1.44, 95% CI=1.34-1.55]. Low, moderate, and high chronic preoperative opioid exposures were predictive of all-cause readmissions (low: OR 1.09, 95% CI: 1.06-1.12); high: OR 1.23, 95% CI: 1.18-1.29)., Conclusions: Higher levels of preoperative opioid exposure are associated with increased risk of readmissions after surgery. These findings emphasize the importance of screening patients for preoperative opioid exposure and creating risk mitigation strategies for patients., Competing Interests: The authors report no conflicts of interest., (Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
17. Dexmedetomidine, Delirium, and Adverse Outcomes: Analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database.
- Author
-
Pal N, Abernathy JH 3rd, Taylor MA, Bollen BA, Shah AS, Feng X, Shotwell MS, and Kertai MD
- Subjects
- Analgesics, Non-Narcotic adverse effects, Delirium etiology, Humans, Incidence, Pain, Postoperative prevention & control, Postoperative Complications etiology, Retrospective Studies, United States epidemiology, Cardiac Surgical Procedures adverse effects, Delirium epidemiology, Dexmedetomidine adverse effects, Postoperative Complications epidemiology, Propensity Score, Societies, Medical statistics & numerical data, Thoracic Surgery statistics & numerical data
- Abstract
Background: We tested the hypothesis that dexmedetomidine was associated with a reduced incidence of postoperative delirium (POD) and adverse outcomes in cardiac surgery patients from The Society of Thoracic Surgeons Adult Cardiac Surgery Database including the Adult Cardiac Anesthesiology subsection., Methods: We identified 55,905 patients in The Society of Thoracic Surgeons Adult Cardiac Surgery Database who underwent cardiac surgery between July 2014 and December 2018. Using propensity score-weighted regression analysis, we analyzed the effect of intraoperative dexmedetomidine on the primary (POD) and secondary outcomes (highest pain score on day 3 and at discharge, stroke, prolonged ventilation, postoperative intubation/reintubation, additional postoperative hours ventilated, renal failure, atrial fibrillation, and 30-day mortality). In separate propensity score-weighted analyses, we examined the effect of postoperative dexmedetomidine on the highest postoperative pain score at discharge and 30-day mortality., Results: The rate of intraoperative dexmedetomidine use was 25.5% (n = 13,963), and its administration was associated with increased odds for POD (odds ratio, 1.85; 95% confidence interval [CI], 1.60-2.13), a small higher average pain score on day 3 (mean difference, 0.08; 95% CI, 0.02-0.14), increased odds for postoperative intubation/reintubation (odds ratio, 1.29; 95% CI, 1.12-1.48), and a small lower average pain score at discharge (mean difference, -0.31; 95% CI, -0.21 to-0.41). Postoperative dexmedetomidine was associated with a small higher average pain score at discharge (mean difference, 0.27; 95% CI, 0.21-0.34) and higher odds for 30-day mortality (odds ratio, 1.25, 95% CI, 1.07-1.46)., Conclusions: In this registry of cardiac surgical patients dexmedetomidine administration was associated with POD and adverse outcomes., (Copyright © 2021 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
18. Comment on Opioids After Surgery in the United States Versus the Rest of the World: The International Patterns of Opioid Prescribing Multicenter Study.
- Author
-
Peters LE, Zhao J, Smith SR, and Pockney P
- Subjects
- Humans, Pain, Postoperative drug therapy, Pain, Postoperative prevention & control, Practice Patterns, Physicians', United States epidemiology, Analgesics, Opioid therapeutic use, Drug Overdose
- Abstract
Competing Interests: The authors report no conflicts of interest.
- Published
- 2021
- Full Text
- View/download PDF
19. Response to the Comment on "Opioids After Surgery in the United States Versus the Rest of the World: The International Patterns of Opioid Prescribing (iPOP) Multicenter Study".
- Author
-
El Moheb M and Kaafarani HMA
- Subjects
- Humans, Pain, Postoperative drug therapy, Pain, Postoperative prevention & control, Practice Patterns, Physicians', United States epidemiology, Analgesics, Opioid therapeutic use, Drug Overdose
- Abstract
Competing Interests: The authors report no conflicts of interest.
- Published
- 2021
- Full Text
- View/download PDF
20. Day-of-Surgery Gabapentinoids and Prolonged Opioid Use: A Retrospective Cohort Study of Medicare Patients Using Electronic Health Records.
- Author
-
Young JC, Dasgupta N, Chidgey BA, Stürmer T, Pate V, Hudgens M, and Jonsson Funk M
- Subjects
- Age Factors, Aged, Analgesics, Non-Narcotic adverse effects, Analgesics, Opioid adverse effects, Drug Administration Schedule, Female, Gabapentin adverse effects, Humans, Male, Pain, Postoperative diagnosis, Pain, Postoperative etiology, Postoperative Care, Preoperative Care, Retrospective Studies, Time Factors, Treatment Outcome, United States, Ambulatory Surgical Procedures adverse effects, Analgesics, Non-Narcotic administration & dosage, Analgesics, Opioid administration & dosage, Electronic Health Records, Gabapentin administration & dosage, Medicare, Pain, Postoperative prevention & control
- Abstract
Background: While preoperative gabapentinoids are commonly used in surgical multimodal analgesia protocols, little is known regarding the effects this therapy has on prolonged postsurgical opioid use. In this observational study, we used data from a large integrated health care system to estimate the association between preoperative day-of-surgery gabapentinoids and the risk of prolonged postsurgical opioid use., Methods: We identified adults age ≥65 years undergoing major therapeutic surgical procedures from a large integrated health care system from 2016 to 2019. Exposure to preoperative gabapentinoids on the day of surgery was measured using inpatient medication administration records, and the outcome of prolonged opioid use was measured using outpatient medication orders. We used stabilized inverse probability of treatment-weighted log-binomial regression to estimate risk ratios and 95% confidence intervals (CIs) of prolonged opioid use, comparing patients who received preoperative gabapentinoids to those who did not and adjusting for relevant clinical factors. The main analysis was conducted in the overall surgical population, and a secondary analysis was conducted among procedures where at least 30% of all patients received a preoperative gabapentinoid., Results: Overall, 13,958 surgical patients met inclusion criteria, of whom 21.0% received preoperative gabapentinoids. The observed 90-day risk of prolonged opioid use following surgery was 0.91% (95% CI, 0.77-1.08). Preoperative gabapentinoid administration was not associated with a reduced risk of prolonged opioid use in the main analysis conducted in a broad surgical population (adjusted risk ratio [adjRR], 1.19 [95% CI, 0.67-2.12]) or in the secondary analysis conducted in patients undergoing colorectal resection, hip arthroplasty, knee arthroplasty, or hysterectomy (adjRR, 1.01 [95% CI, 0.30-3.33])., Conclusions: In a large integrated health system, we did not find evidence that preoperative gabapentinoids were associated with reduced risk of prolonged opioid use in patients undergoing a broad range of surgeries., Competing Interests: Conflicts of Interest: See Disclosures at the end of the article., (Copyright © 2021 International Anesthesia Research Society.)
- Published
- 2021
- Full Text
- View/download PDF
21. Anesthesia Related to Breast Cancer Recurrence and Chronic Pain: A Review of Current Research.
- Author
-
Kujawa E, Blau A, and Rametta L
- Subjects
- Adult, Female, Humans, Middle Aged, United States, Anesthesia standards, Breast Neoplasms surgery, Chronic Pain prevention & control, Mastectomy standards, Neoplasm Recurrence, Local prevention & control, Pain, Postoperative prevention & control, Practice Guidelines as Topic
- Abstract
Patients with breast cancer often require several procedures requiring anesthesia, such as central venous catheter placements, mastectomies, lymph node dissections, and reconstructive surgeries. Recent research findings have suggested there may be a reduced risk of cancer recurrence and chronic pain with specific anesthetic techniques. Regional techniques, total intravenous anesthetics, and select adjuncts have been reviewed to identify their role in breast cancer recurrence and chronic pain. A review of the pathophysiology as it pertains to volatile anesthetics, propofol as a total intravenous anesthetic, paravertebral nerve blocks, dexmedetomidine, and ketorolac, as well as the role each of these plays in the prevention of chronic pain and cancer recurrence is provided. Current research and recommendations for practice are presented in the context of providing anesthesia to mitigate chronic pain and cancer recurrence in patients with breast cancer., Competing Interests: Name: Emily Kujawa, DNAP, CRNA Contribution: This author made significant contributions to the conception, synthesis, writing, and final editing and approval of the manuscript to justify inclusion as an author. Disclosures: None. Name: Alissa Blau, DNAP, CRNA Contribution: This author made significant contributions to the conception, synthesis, writing, and final editing and approval of the manuscript to justify inclusion as an author. Disclosures: None. Name: Lauryn Rametta, DNAP, CRNA Contribution: This author made significant contributions to the conception, synthesis, writing, and final editing and approval of the manuscript to justify inclusion as an author. Disclosures: None. The authors did not discuss off-label use within the article. Disclosure statements are available for viewing upon request., (Copyright © by the American Association of Nurse Anesthetists.)
- Published
- 2021
22. Perioperative pain management and opioid-reduction in head and neck endocrine surgery: An American Head and Neck Society Endocrine Surgery Section consensus statement.
- Author
-
Ferrell JK, Shindo ML, Stack BC Jr, Angelos P, Bloom G, Chen AY, Davies L, Irish JC, Kroeker T, McCammon SD, Meltzer C, Orloff LA, Panwar A, Shin JJ, Sinclair CF, Singer MC, Wang TV, and Randolph GW
- Subjects
- Consensus, Humans, Pain, Postoperative drug therapy, Pain, Postoperative prevention & control, Parathyroidectomy, Thyroidectomy adverse effects, United States, Analgesics, Opioid therapeutic use, Pain Management
- Abstract
Background: This American Head and Neck Society (AHNS) consensus statement focuses on evidence-based comprehensive pain management practices for thyroid and parathyroid surgery. Overutilization of opioids for postoperative pain management is a major contributing factor to the opioid addiction epidemic however evidence-based guidelines for pain management after routine head and neck endocrine procedures are lacking., Methods: An expert panel was convened from the membership of the AHNS, its Endocrine Surgical Section, and ThyCa. An extensive literature review was performed, and recommendations addressing several pain management subtopics were constructed based on best available evidence. A modified Delphi survey was then utilized to evaluate group consensus of these statements., Conclusions: This expert consensus provides evidence-based recommendations for effective postoperative pain management following head and neck endocrine procedures with a focus on limiting unnecessary use of opioid analgesics., (© 2021 Wiley Periodicals LLC.)
- Published
- 2021
- Full Text
- View/download PDF
23. A Quality Improvement Project to Reduce Postcesarean Opioid Consumption.
- Author
-
Kahn KM, Demarco K, Pavsic J, and Sangillo J
- Subjects
- Analgesics, Opioid therapeutic use, Cesarean Section adverse effects, Female, Humans, Infant, Newborn, Opioid-Related Disorders drug therapy, Pain, Postoperative prevention & control, Postoperative Care, Pregnancy, United States, Analgesics, Opioid adverse effects, Pain, Postoperative drug therapy, Quality Improvement
- Abstract
Background: The opioid epidemic is a public health emergency in the United States, stemming in part from widespread misuse and overprescribing of opioids following surgery. Approximately 1 in 300 women with no prior exposure to opioids develops an opioid use disorder following cesarean birth. Effective management of postcesarean pain requires individualized treatment and a balance of the woman's goals for optimal recovery and ability to safely care for her newborn. The American College of Obstetricians and Gynecologists recommends a multimodal approach to pain management after cesarean birth., Methods: In April 2019, a multidisciplinary team was formed at New York University Langone Health to study opioid use postcesarean. The team used the Plan, Do, Study, Act process model for continuous quality improvement to launch a postcesarean pathway called "Your Plan After Cesarean," a standardized visual tool with quantifiable milestones. It facilitates integration of women's preferences in their postcesarean care, and emphasizes providers' routine use of nonpharmacological interventions to manage pain., Results: During the pilot period of the project, postcesarean high consumption of 55 to 120 mg of opioids was reduced from 25% to 8%. By January 2020, 75% of women postoperative cesarean took little-to-no opioids during their hospital stay. By February 2021, the total number of opioids consumed by women after cesarean birth in-hospital was reduced by 79%. Satisfaction among women with pain management after cesarean continued to be high., Clinical Implications: Reduction in postcesarean opioid administration and the number of opioids prescribed at hospital discharge can be accomplished without having a negative effect on women's perceptions of post-op pain relief. These changes can potentially be a factor in helping to avoid an opioid-naive woman who has a cesarean birth from developing an opioid use disorder., (Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
24. Association between sex and perioperative opioid prescribing for total joint arthroplasty: a retrospective population-based study.
- Author
-
Soffin EM, Wilson LA, Liu J, Poeran J, and Memtsoudis SG
- Subjects
- Analgesics, Opioid adverse effects, Databases, Factual, Drug Administration Schedule, Drug Prescriptions, Drug Utilization trends, Female, Humans, Male, Middle Aged, Pain Management adverse effects, Pain, Postoperative diagnosis, Pain, Postoperative etiology, Perioperative Care trends, Retrospective Studies, Risk Assessment, Risk Factors, Sex Factors, Treatment Outcome, United States, Analgesics, Opioid administration & dosage, Arthroplasty, Replacement, Hip adverse effects, Arthroplasty, Replacement, Knee adverse effects, Healthcare Disparities trends, Pain Management trends, Pain, Postoperative prevention & control, Practice Patterns, Physicians' trends
- Abstract
Background: Scarce data exist on differential opioid prescribing between men and women in the pre-, peri-, and postoperative phases of care among patients undergoing total hip/knee arthroplasty (THA/TKA)., Methods: In this retrospective population-based study, Truven Health MarketScan claims data were used to establish differences between men and women in (1) opioid prescribing in the year before THA/TKA surgery, (2) the amount of opioids prescribed at discharge, and (3) chronic opioid prescribing (3-12 months after surgery). Multivariable regression models measured odds ratios (OR) with 95% confidence intervals (95% CI)., Results: Among 29 038 THAs (42% men) and 48 523 TKAs (52% men) men (compared with women) were less likely to receive an opioid prescription in the year before surgery (54% vs 60%, and 54% vs 60% for THA and TKA, respectively); P<0.001. However, in multivariable analyses male sex was associated with higher total opioid dosages prescribed at discharge after THA (OR=1.04; 95% CI 1.03, 1.06) and TKA (OR=1.05; 95% CI 1.04, 1.06); both P<0.001. Chronic opioid prescribing was found in 10% of the cohort (THA: n=2333; TKA: n=5365). Here, men demonstrated lower odds of persistent opioid prescribing specifically after THA (OR=0.90; 95% CI 0.82, 0.99) but not TKA (OR=0.96; 95% CI 0.90, 1.02); P=0.026 and P=0.207, respectively., Conclusions: We found sex-based differences in opioid prescribing across all phases of care for THA/TKA. The results highlight temporal opportunities for targeted interventions to improve outcomes after total joint arthroplasty, particularly for women, and to decrease chronic opioid prescribing., (Copyright © 2021 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
25. Postoperative opioid administration characteristics associated with opioid-induced respiratory depression: Results from the PRODIGY trial.
- Author
-
Urman RD, Khanna AK, Bergese SD, Buhre W, Wittmann M, Le Guen M, Overdyk FJ, Di Piazza F, and Saager L
- Subjects
- Analgesics, Opioid adverse effects, Asia, Capnography, Humans, Pain, Postoperative drug therapy, Pain, Postoperative epidemiology, Pain, Postoperative prevention & control, United States, Respiratory Insufficiency chemically induced, Respiratory Insufficiency epidemiology, Tramadol
- Abstract
Study Objective: Opioid administration for pain in general care floor patients remains common, and can lead to adverse outcomes, including respiratory compromise. The PRODIGY trial found that among ward patients receiving parenteral opioids, 46% experienced ≥1 respiratory depression episode. The objective of this analysis was to evaluate the geographic differences of opioid administration and examine the association between opioid administration characteristics and the occurrence of respiratory depression., Design: Prospective observational trial., Setting: 16 general care medical and surgical wards in Asia, Europe, and the United States., Patients: 1335 patients receiving parenteral opioids., Interventions: Blinded, alarm-silenced continuous capnography and pulse oximetry monitoring., Measurements: Opioid-induced respiratory depression, defined as respiratory rate ≤ 5 bpm, SpO
2 ≤ 85%, or ETCO2 ≤ 15 or ≥ 60 mmHg for ≥3 min; apnea episode lasting >30 s; or any respiratory opioid-related adverse event., Results: Across all patients, 58% received only long-acting opioids, 16% received only short-acting (<3 h) opioids, and 21% received a combination of short- and long-acting (≥3 h) opioids. The type and median total morphine milligram equivalent (MME) of opioid administered varied significantly by region, with 31.5 (12.5-76.7) MME, 31.0 (6.2-99.0) MME, and 7.2 (1.7-18.7) MME in the United States, Europe, and Asia, respectively (p < 0.001). Considering only postoperative opioids, 54% (N = 119/220) and 45% (N = 347/779) of patients receiving only short-acting opioids or only long-acting opioids experienced ≥1 episode of opioid-induced respiratory depression, respectively. Multivariable analysis identified post-procedure tramadol (OR 0.62, 95% CI 0.424-0.905, p = 0.0133) and post-procedure epidural opioids (OR 0.485, 95% CI 0.322-0.731, p = 0.0005) being associated with a significant reduction in opioid-induced respiratory depression., Conclusions: Despite varying opioid administration characteristics between Asia, Europe, and the United States, opioid-induced respiratory depression remains a common global problem on general care medical and surgical wards. While the use of post-procedure tramadol or post-procedure epidural opioids may reduce the incidence of respiratory depression, continuous monitoring is also necessary to ensure patient safety when receiving postoperative opioids. REGISTRATION NUMBER: www.clinicaltrials.gov, ID: NCT02811302., (Copyright © 2021 Elsevier Inc. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
26. Persistent opioid use after surgical treatment of paediatric fracture.
- Author
-
Zhong H, Ladenhauf HN, Wilson LA, Liu J, DelPizzo KR, Poeran J, and Memtsoudis SG
- Subjects
- Adolescent, Age Factors, Analgesics, Opioid adverse effects, Child, Child, Preschool, Databases, Factual, Drug Administration Schedule, Drug Prescriptions, Drug Utilization, Female, Humans, Infant, Infant, Newborn, Male, Pain, Postoperative diagnosis, Pain, Postoperative etiology, Practice Patterns, Physicians', Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, Treatment Outcome, United States, Young Adult, Analgesics, Opioid administration & dosage, Fracture Fixation adverse effects, Fractures, Bone surgery, Pain, Postoperative prevention & control
- Abstract
Background: The opioid epidemic is one of the most pressing public health crises in the USA. With fractures being amongst the most common reasons for a child to require surgical intervention and receive post-surgical pain management, characterisation of opioid prescription patterns and risk factors is critical. We hypothesised that the numbers of paediatric patients receiving opioids, or who developed persistent opioid use, are significant, and a number of risk factors for persistent opioid use could be identified., Methods: We conducted a retrospective population-based cohort study. National claims data from the Truven Health Analytics® MarketScan database were used to (i) characterise opioid prescription patterns and (ii) describe the epidemiology and risk factors for single use and persistent use of opioids amongst paediatric patients who underwent surgical intervention for fracture treatment., Results: Amongst 303 335 patients, 21.5% received at least one opioid prescription within 6 months after surgery, and 1671 (0.6%) developed persistent opioid use. Risk factors for persistent opioid use include older age; female sex; lower extremity trauma; surgeries involving the spine, rib cage, or head; closed fracture treatment; earlier surgery years; previous use of opioid; and higher comorbidity burden., Conclusions: Amongst a cohort of paediatric patients who underwent surgical fracture treatment, 21.5% filled at least one opioid prescription, and 0.6% (N=1671) filled at least one more opioid prescription between 3 and 6 months after surgery. Understanding risk factors related to persistent opioid use can help clinicians devise strategies to counter the development of persistent opioid use for paediatric patients., Competing Interests: Declarations of interest SGM is a director on the boards of the American Society of Regional Anesthesia and Pain Medicine and the Society of Anesthesia and Sleep Medicine; a one-time consultant for Sandoz, Inc. and Teikoku, and is currently on the medical advisory board of HATH; He has a pending US patent application for a Multicatheter Infusion System (US-2017-0361063); and is the owner of SGM Consulting, LLC and co-owner of FC Monmouth, LLC. None of the aforementioned relations influenced the conduct of the present study. All other authors declare no conflicts of interest., (Copyright © 2021 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
27. Keeping tabs: Reducing postoperative opioid prescriptions for patients after breast surgical procedures.
- Author
-
Gunasingha RMKD, Niloy IL, Wetstein BB, Learn PA, and Turza LC
- Subjects
- Adult, Age Factors, Aged, Aged, 80 and over, Drug Prescriptions statistics & numerical data, Enhanced Recovery After Surgery, Female, Humans, Mastectomy adverse effects, Middle Aged, Prospective Studies, Reoperation adverse effects, Sex Factors, United States, Young Adult, Analgesics, Opioid administration & dosage, Breast Neoplasms surgery, Pain Management methods, Pain, Postoperative prevention & control, Practice Patterns, Physicians' statistics & numerical data
- Abstract
Background: As the opioid crisis continues, it is critical that health care providers ensure they are not overprescribing opioid medications. At our institution (Walter Reed National Military Medical Center, Bethesda, MD), postoperative patients after breast surgeries are discharged with variable amounts of opioid medications. However, many patients report minimal opioid use. The objectives of this study were to characterize postoperative opioid usage and prescribing practices for patients undergoing various breast surgeries and to recommend the number of opioid pills for discharge for each procedure., Methods: This was a prospective, single-institution study of all patients undergoing breast surgery from October 2018 to 2019. All patients were enrolled in our institution's enhanced recovery after surgery protocol. Patients were given questionnaires at their 2-week postoperative clinic appointment that evaluated perioperative pain and use of pain medications. The electronic medical record was reviewed to obtain additional information. Appropriate parametric and nonparametric tests were used for analysis., Results: A total of 190 breast surgery patients completed the survey. We observed no significant differences in pain scores except between re-excision and mastectomy. Of these patients, 99% were prescribed opioids; however, only 53% of patients used them. Of those patients who were prescribed opioids, on average, all were prescribed more pills than were used., Conclusion: Our study demonstrates that it is possible to discharge all breast surgery patients with fewer than 10 opioid pills, except for special circumstances. This is the first study to provide a set of specific recommended discharge medications. Utilization of an enhanced recovery after surgery protocol with standardized discharge opioids can be used successfully to reduce the number of opioids prescribed to patients., (Published by Elsevier Inc.)
- Published
- 2021
- Full Text
- View/download PDF
28. Superior Hypogastric Plexus Block to Reduce Pain After Laparoscopic Hysterectomy: A Randomized Controlled Trial.
- Author
-
Clark NV, Moore K, Maghsoudlou P, North A, Ajao MO, Einarsson JI, Louie M, Schiff L, Moawad G, Cohen SL, and Carey ET
- Subjects
- Adult, Female, Humans, Middle Aged, Pain Measurement, Treatment Outcome, United States, Hypogastric Plexus, Hysterectomy, Laparoscopy, Nerve Block, Pain, Postoperative prevention & control
- Abstract
Objective: To assess whether a superior hypogastric plexus block performed during laparoscopic hysterectomy reduces postoperative pain., Methods: We conducted a multicenter, randomized, single-blind, controlled trial of superior hypogastric plexus block at the start of laparoscopic hysterectomy. Women undergoing a laparoscopic hysterectomy for any indication and with any other concomitant laparoscopic procedure were eligible. Standardized preoperative medications and incisional analgesia were provided to all patients. Our primary outcome was the proportion of patients with a mean visual analog scale (VAS) pain score lower than 4 within 2 hours postoperatively. Patients but not surgeons were blinded to the treatment group. Twenty-nine patients per group was estimated to be sufficient to detect a 38% absolute difference in the proportion of patients with a VAS score lower than 4 at 2 hours postoperatively, with 80% power and an α of 0.05. To account for loss to follow-up and potential imbalances in patient characteristics, we planned to enroll 50 patients per group. All analyses were intention to treat., Results: Between January 2018 and February 2019, 186 patients were eligible; 100 were randomized and analyzed. Demographic and clinical characteristics were similar between the two groups. There was no significant difference in the proportion of patients with a mean VAS score lower than 4 within 2 hours postoperatively between patients who received a superior hypogastric plexus block (57%) and patients who did not (43%) (odds ratio 1.63, 95% CI 0.74-3.59; adjusted odds ratio 1.84, 95% CI 0.75-4.51)., Conclusion: Among patients undergoing laparoscopic hysterectomy with standardized enhanced perioperative recovery pathways, superior hypogastric plexus block did not significantly reduce postoperative pain., Clinical Trial Registration: ClinicalTrials.gov, NCT03283436., Competing Interests: Financial Disclosure Michelle Louie disclosed receiving funds from Hologic. Gaby Moawad reports receiving funds from Intuitive Surgical outside the submitted work. Sarah Cohen was an Advisory Board Member for Myovant (2020) and Boston Scientific (2018). Erin Carey reports money was paid to her institution for expert testimony and money was paid to her from Med IQ and Teleflex Surgical. The other authors did not report any potential conflicts of interest., (Copyright © 2021 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
29. A national evaluation of opioid prescribing and persistent use after ambulatory anorectal surgery.
- Author
-
Keller DS, Kenney BC, Harbaugh CM, Waljee JF, and Brummett CM
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Ambulatory Care Facilities, Comorbidity, Digestive System Surgical Procedures adverse effects, Digestive System Surgical Procedures methods, Disease Management, Female, Health Care Surveys, Humans, Male, Middle Aged, Outcome Assessment, Health Care, Pain, Postoperative drug therapy, Pain, Postoperative etiology, Pain, Postoperative prevention & control, United States epidemiology, Young Adult, Ambulatory Care statistics & numerical data, Analgesics, Opioid administration & dosage, Analgesics, Opioid therapeutic use, Digestive System Surgical Procedures statistics & numerical data, Drug Prescriptions statistics & numerical data, Pain, Postoperative epidemiology, Practice Patterns, Physicians' statistics & numerical data
- Abstract
Background: Surgery is a common gateway to opioid-related morbidity. Ambulatory anorectal cases are common, with opioids widely prescribed, but there is limited data on their role in this crisis. We sought to determine prescribing trends, new persistent opioid use rates, and factors associated with new persistent opioid use after ambulatory anorectal procedures., Methods: The Optum Clinformatics claims database was analyzed for opioid-naïve adults undergoing outpatient hemorrhoid, fissure, or fistula procedures from January 1, 2010, to June 30, 2017. The main outcome measure was the rate of new persistent opioid use after anorectal cases. Secondary outcomes were annual rates of perioperative opioid fills and the prescription size over time (oral morphine equivalents)., Results: A total of 23,426 cases were evaluated: 69.09% (n = 16,185) hemorrhoids, 24.29% (n = 5,690) fissures, and 6.45% (n = 1,512) fistulas. The annual rate of perioperative opioid fills decreased on average 1.2%/year, from 72% in 2010 to 66% in 2017 (P < .001). Prescribing rates were consistently highest for fistulas, followed by hemorrhoids, then fissures (P < .001). There was a significant reduction in prescription size (oral morphine equivalents) over the study period, with median oral morphine equivalents (interquartile range) of 280 (250-400) in 2010 and 225 (150-375) in 2017 (P < .0001). Overall, 2.1% (n = 499) developed new persistent opioid use. Logistic regression found new persistent opioid use was associated with additional perioperative opioid fills (odds ratio 3.92; 95% confidence interval: 2.92-5.27; P < .0001), increased comorbidity (odds ratio 1.15; confidence interval: 1.09-1.20; P < .00001), tobacco use (odds ratio 1.79; confidence interval: 1.37-2.36; P < .0001), and pain disorders (odds ratio, 1.49; confidence interval, 1.23-1.82); there was no significant association with procedure performed., Conclusion: Over 2% of ambulatory anorectal procedures develop new persistent opioid use. Despite small annual reductions in opioid prescriptions, there has been little change in the amount prescribed. This demonstrates a need to develop and disseminate best practices for anorectal surgery, focusing on eliminating unnecessary opioid prescribing., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
30. Narcotic Refills and Patient Satisfaction With Pain Control After Total Joint Arthroplasty.
- Author
-
Stambough JB, Hui R, Siegel ER, Edwards PK, Barnes CL, and Mears SC
- Subjects
- Aftercare, Aged, Analgesics, Opioid, Humans, Medicare, Pain, Postoperative drug therapy, Pain, Postoperative epidemiology, Pain, Postoperative prevention & control, Patient Discharge, Retrospective Studies, United States, Narcotics, Patient Satisfaction
- Abstract
Background: Patient satisfaction has become an important metric for total joint arthroplasty (TJA) used to reimburse hospitals. Despite ubiquitous narcotic use for post-TJA pain control, there is little understanding regarding patient factors associated with obtaining opioid refills and associations with patient satisfaction., Methods: Using our state's mandatory opioid prescription monitoring program, we reviewed preoperative and postoperative narcotic prescriptions filled for 438 consecutive TJA patients. Subjects were divided into 3 groups based on the number of post-TJA narcotic refills obtained (0, 1, or >1), and logistic regression analysis was conducted comparing demographics, surgical factors, and satisfaction with pain control., Results: One hundred twenty-five patients (25.8%) did not consume preoperative opioids and received no postoperative refills. Total hip arthroplasty (THA) patients (P = .0004), subjects ≥65 years (P = .0057), and Medicare patients (P = .0058) had significantly higher rates of 0 postdischarge refills. THA recipients had 268% increased odds of not receiving a refill narcotic (adjusted odds ratio = 0.373; 95% confidence interval, 0.224- 0.622). Every 100-morphine milligram equivalent (MME) increase in presurgery use led to a 16% increase in odds of needing >1 opioid refill (adjusted odds ratio = 1.161; 95% confidence interval, 1.085-1.242). Subjects who noted higher satisfaction consumed less overall opioids when receiving a refill (436 vs 1119 MMEs, P = .021)., Conclusion: Subjects who received fewer narcotic prescriptions and overall MMEs demonstrated higher rates of satisfaction with early pain control. Our results are consistent with other studies in showing that increased preoperative narcotic use portends higher rates of postoperative refills. There appears to be a subset of THA patients >65 years of age who may be candidates for opioid-sparing analgesia., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
31. Reduction of Opioids Prescribed Upon Discharge After Total Knee Arthroplasty Significantly Reduces Consumption: A Prospective Study Comparing Two States.
- Author
-
Chalmers BP, Mayman DJ, Jerabek SA, Sculco PK, Haas SB, and Ast MP
- Subjects
- Cohort Studies, Humans, Middle Aged, Pain, Postoperative drug therapy, Pain, Postoperative epidemiology, Pain, Postoperative prevention & control, Patient Discharge, Practice Patterns, Physicians', Prospective Studies, Retrospective Studies, United States, Analgesics, Opioid, Arthroplasty, Replacement, Knee adverse effects
- Abstract
Background: Opioids prescribed for acute pain after total knee arthroplasty (TKA) play a contributing role in the number of opioid pills in circulation. At the height of an opioid epidemic in the United States, opioids are increasingly diverted, misused, and abused. Therefore, many states have enacted narcotic regulations in an attempt to curb opioid diversion and misuse. The purpose of this study is to evaluate the effect of stricter state prescribing regulations on opioid consumption following TKA., Methods: In total, 165 opioid-naive patients undergoing primary unilateral TKA at a single institution with a standardized perioperative pain protocol were reviewed. Seventy-one patients (group 1) resided in a state with strict opioid regulations that limit the initial number of pills dispensed and refills, whereas 92 patients (group 2) resided in another state without quantity and refill regulations. Patient demographics were similar between the 2 groups. Mean age was 64 and mean body mass index was 32 kg/m
2 . Opioid consumption, quantity, and refill patterns were collected for 6 weeks following surgery., Results: The average oral morphine equivalents consumed during the 6 weeks postsurgery were significantly lower in group 1 at 446.3 ± 266.3 mg (range 10-992) compared to group 2 at 622.6 ± 313.7 mg (range 20-1416) (P < .001). The average oral morphine equivalent corresponds to 60 tablets of 5 mg oxycodone per patient in group 1 vs 84 tablets per patient in group 2. Fifty-nine (83%) patients in group 1 had stopped taking opioids within 6 weeks of surgery compared to 59 (64%) in group 2 (P = .04)., Conclusion: Based on our results, the institution of state regulations aimed at decreasing the quantity and refills of postoperative opioids led patients to consume less opioids following TKA. Many patients are prescribed more opioids than they require which increases their consumption and can increase the risk for diversion, addiction, and misuse., Level of Evidence: Level III; retrospective comparative cohort study., (Copyright © 2020 Elsevier Inc. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
32. Perioperative Pain Management after Ambulatory Abdominal Surgery: An American College of Surgeons Systematic Review.
- Author
-
Hu QL, Dworsky JQ, Beck AC, Gilbert EW, Pockaj BA, Varghese TK Jr, Maggard-Gibbons M, Ko CY, Weigel RJ, and Laronga C
- Subjects
- Humans, Societies, Medical, United States, Ambulatory Surgical Procedures, Pain Management standards, Pain Measurement standards, Pain, Postoperative prevention & control, Perioperative Care standards
- Published
- 2020
- Full Text
- View/download PDF
33. Feasibility of a Local Anesthesia Program for Inguinal Hernia Repair at a Veteran Affairs Hospital.
- Author
-
Loss L, Meier J, Ordonez JE, Phung T, Balentine C, Zhu H, and Huerta S
- Subjects
- Aged, Feasibility Studies, Female, Hospitals, Veterans statistics & numerical data, Humans, Male, Middle Aged, Operative Time, Pain Measurement statistics & numerical data, Pain, Postoperative diagnosis, Pain, Postoperative etiology, Patient Satisfaction, Retrospective Studies, Treatment Outcome, United States, Anesthesia, General statistics & numerical data, Anesthesia, Local statistics & numerical data, Elective Surgical Procedures adverse effects, Hernia, Inguinal surgery, Herniorrhaphy adverse effects, Pain, Postoperative prevention & control
- Abstract
Background: Local anesthesia (LA) for open inguinal hernia repair (OIHR) is not widely used in the United States. An LA program for OIHR was initiated at the Dallas Veteran Affairs Medical Center in 2015. We hypothesize that outcomes under LA for OIHR are similar to general anesthesia with adequate patient satisfaction., Methods: A total of 1422 groin hernias were performed by a single surgeon using a standardized technique at the Dallas Veteran Affairs Medical Center (2015-2019). Only unilateral, primary, elective, OIHRs were included (n = 1092). LA was used in 26.0% (n = 285) and compared with patients undergoing general anesthesia. Univariate analysis was performed by the Student t-test for continuous variables and χ
2 test (or the Fisher exact test) for categorical variables., Results: OIHR performed with LA increased from 15.5% in 2015 to 76.6% in 2019. Patients undergoing LA were older and had significantly more comorbidities. Holding time to operating room (OR), OR to start of the operation, skin-to-skin time, and end of the operation to out of the OR were all reduced with LA (all P values <0.05). Inguinodynia, recurrence, and overall complications were similar. Patients undergoing LA indicated that they were comfortable (93.0%), rated their worst pain as 2.03 ± 2.2 (of 10), and would undergo LA if they had to do it again (94.0%)., Conclusions: LA was associated with decreased OR times and had good patient satisfaction. Overall complication rates were similar despite a higher burden of comorbid conditions in patients undergoing LA., (Published by Elsevier Inc.)- Published
- 2020
- Full Text
- View/download PDF
34. Opioid free anesthesia: feasible?
- Author
-
Chia PA, Cannesson M, and Bui CCM
- Subjects
- Analgesics, Non-Narcotic administration & dosage, Humans, Pain Management trends, United States, Analgesia methods, Analgesics, Non-Narcotic therapeutic use, Analgesics, Opioid adverse effects, Pain, Postoperative prevention & control
- Abstract
Purpose of Review: The present review aims to address the feasibility of opioid free anesthesia (OFA). The use of opioids to provide adequate perioperative pain management has been a central practice of anesthesia, and only recently has been challenged. Understanding the goals and challenges of OFA is essential as the approach to intraoperative analgesia and postsurgical management of pain has shifted in response to the opioid epidemic in the United States., Recent Findings: OFA is an opioid sparing technique, which focuses on multimodal or balanced analgesia, relying on nonopioid adjuncts and regional anesthesia. Enhanced recovery after surgery protocols, often under the auspices of a perioperative pain service, can help guide and promote opioid reduced and OFA, without negatively impacting perioperative pain management or recovery., Summary: The feasibility of OFA is evident. However, there are limitations of this approach that warrant discussion including the potential for adverse drug interactions with multimodal analgesics, the need for providers trained in regional anesthesia, and the management of pain expectations. Additionally, minimizing opioid use perioperatively also requires a change in current prescribing practices. Monitors that can reliably quantify nociception would be helpful in the titration of these analgesics and enable anesthesiologists to achieve the goal in providing personalized perioperative medicine.
- Published
- 2020
- Full Text
- View/download PDF
35. An analysis of analgesia and opioid prescribing for veterans after thoracic surgery.
- Author
-
Pommerening MJ, Landau A, Hrebinko K, Luketich JD, and Dhupar R
- Subjects
- Aged, Analgesia methods, Drug Prescriptions standards, Drug Prescriptions statistics & numerical data, Female, Humans, Male, Middle Aged, Opioid-Related Disorders epidemiology, Opioid-Related Disorders etiology, Pain Management adverse effects, Pain, Postoperative etiology, Pain, Postoperative prevention & control, Patient Discharge standards, Patient Discharge statistics & numerical data, Practice Guidelines as Topic, Practice Patterns, Physicians' standards, Practice Patterns, Physicians' statistics & numerical data, Retrospective Studies, United States, United States Department of Veterans Affairs standards, United States Department of Veterans Affairs statistics & numerical data, Veterans statistics & numerical data, Analgesia statistics & numerical data, Analgesics, Opioid adverse effects, Opioid Epidemic prevention & control, Pain Management statistics & numerical data, Pain, Postoperative drug therapy, Thoracic Surgical Procedures adverse effects
- Abstract
The opioid crisis is a public health issue and has been linked to physician overprescribing. Pain management after thoracic surgery is not standardized at many centers, and we hypothesized that excessive narcotics were being dispensed on discharge. As a quality improvement initiative, we sought to understand current prescribing practices to better align the amount of opioids dispensed on discharge to actual patient needs. This was a single-center, retrospective review of patients undergoing thoracic surgery from 7/2015 to 7/2018. Demographics, operative data, perioperative pain medication use, and discharge pain medication prescriptions were analyzed. Opioids were converted to Morphine Milligram Equivalents (MME). Among 124 patients, 103 (83%) received intraoperative nerve blocks and 106 (85.5%) used PCAs. Prescribed MME/day at discharge were significantly higher than MME/day received during hospitalization (Median 30 [IQR 30-45] vs. 15 [IQR 5-24], p < 0.001) and were not associated with receiving a nerve block or PCA. By procedure, prescribed MME/day were significantly higher than inpatient MME/day for wedge resections (p < 0.001), segmentectomies (p = 0.02), lobectomies (p = 0.003), and thymectomies (p = 0.02). Patients are being discharged with significantly more opioids than they are using as inpatients. Education among prescribers and a standardized approach with patient-specific dosing may reduce excessive opioid dispensing.
- Published
- 2020
- Full Text
- View/download PDF
36. The Impact of Epidural Analgesia on Perioperative Morbidity or Mortality after Open Abdominal Aortic Aneurysm Repair.
- Author
-
Greco KJ, Brovman EY, Nguyen LL, and Urman RD
- Subjects
- Aged, Aged, 80 and over, Aortic Aneurysm, Abdominal diagnostic imaging, Aortic Aneurysm, Abdominal mortality, Blood Transfusion, Databases, Factual, Female, Humans, Length of Stay, Male, Middle Aged, Pain, Postoperative diagnosis, Pain, Postoperative etiology, Pain, Postoperative mortality, Patient Readmission, Reoperation, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, Treatment Outcome, United States, Analgesia, Epidural adverse effects, Analgesia, Epidural mortality, Aortic Aneurysm, Abdominal surgery, Blood Vessel Prosthesis Implantation adverse effects, Blood Vessel Prosthesis Implantation mortality, Pain, Postoperative prevention & control
- Abstract
Background: Epidural analgesia (EA) is frequently used as an adjuvant to general anesthesia (GA) for improved postoperative analgesia and reduced rates of cardiac, pulmonary, and renal complications. However, only a few studies have examined EA-GA specifically during open abdominal aortic aneurysm (AAA) repair. The effects of EA-GA specifically during open AAA repair regarding postoperative outcomes are unknown. This study was performed to evaluate postoperative outcomes in patients undergoing open AAA repair with EA-GA versus GA alone., Methods: We performed a retrospective analysis for patients undergoing surgery between January 1, 2014 and December 31, 2016 using the National Surgical Quality Improvement Program (NSQIP) database. Propensity score matching was used to establish cohorts for analysis. Multivariable logistic regression was performed to determine significant perioperative outcomes for each anesthesia type. A total of 2,171 patients underwent open AAA repair in our date range; we excluded emergent and ruptured AAA. A total of 2,145 patients were included in our analysis, of whom 653 patients received EA-GA and 1,492 patients received GA only., Results: Major postoperative outcomes included mortality, pulmonary cardiac and renal complications, infections, thrombosis, and blood transfusion requirement (including Cell-Saver usage). Additional overall outcomes included hospital length of stay, return to the operating room, and readmission. Patients in EA + GA and GA alone groups were comparable regarding demographics, functional status, and comorbidities. Decreased odds of readmission was observed in EA + GA compared with GA (0.49, 95% CI [0.28-0.86]; P = 0.014); and increased odds of receiving a blood transfusion was observed in those who underwent EA + GA (1.63, 95% CI [1.23-2.14]; P = 0.001). No difference was observed between patients who had an AAA repair with EA + GA versus GA alone with regard to mortality, return to operating room, major pulmonary, cardiac, renal, or infectious complications., Conclusions: EA + GA was not associated with decreased mortality or decreased rates of major postoperative pulmonary, cardiac, or renal complications. EA + GA was associated with increased transfusion requirements and decreased rates of hospital readmission., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
37. Opioid-free postoperative analgesia: Is it feasible?
- Author
-
Baboli KM, Liu H, and Poggio JL
- Subjects
- Analgesics, Opioid administration & dosage, Feasibility Studies, Humans, Nerve Block, Pain, Postoperative prevention & control, Randomized Controlled Trials as Topic, United States, Analgesia, Patient-Controlled methods, Analgesics, Non-Narcotic administration & dosage, Analgesics, Opioid adverse effects, Opioid-Related Disorders prevention & control, Pain, Postoperative drug therapy
- Published
- 2020
- Full Text
- View/download PDF
38. Safety and efficacy data supporting U.S. FDA approval of intracameral phenylephrine and ketorolac 1.0%/0.3% for pediatric cataract surgery: clinical safety and pupil and pain management.
- Author
-
Wilson ME, Trivedi RH, and Plager DA
- Subjects
- Anti-Inflammatory Agents, Non-Steroidal, Child, Child, Preschool, Double-Blind Method, Humans, Infant, Infant, Newborn, Pain Management, Pain, Postoperative drug therapy, Pain, Postoperative prevention & control, Phenylephrine, Pupil, United States, Cataract, Ketorolac
- Abstract
Purpose: To assess the safety of phenylephrine and ketorolac (PE/K) 1.0%/0.3% compared with phenylephrine (PE) 1.0% in children aged 0 to 3 years undergoing cataract surgery. The effect of PE/K to PE on intraoperative pupil diameter and postoperative pain were also compared., Setting: Multicenter study in the United States., Design: Randomized double-masked phase 3 clinical trial., Methods: This study was powered to assess safety only. Depending on randomization, 4 mL of PE/K 1.0%/0.3% or PE 1.0% was injected into the surgical irrigation solution. Safety endpoints were assessed up to 90 days postoperatively. From surgical videos, a masked central reader measured the change in pupil diameter from immediately prior to incision to wound closure. Postoperative pain was measured using Alder Hey Triage Pain Score at 3 hours, 6 hours, 9 hours, and 24 hours following wound closure and recorded by parent/caregiver., Results: Seventy-two patients received masked intervention. There were no notable changes in vital signs or ophthalmological complications in either group. Mean change in pupil diameter was similar between PE/K 1.0%/0.3% and PE 1.0% (mean difference in area under the curve -0.071; P = .599). Postoperative ocular pain scores and overall mean scores were lower in PE/K group at all individual time points, and differences in overall mean scores were statistically significant at 6 and 24 hours (P = .029 and 0.021, respectively)., Conclusions: PE/K 1.0%/0.3% was safe for use in children and maintained mydriasis during cataract surgery. Postoperative pain levels were lower in the PE/K 1.0%/0.3% group.
- Published
- 2020
- Full Text
- View/download PDF
39. Drug Enforcement Agency 2014 Hydrocodone Rescheduling Rule and Opioid Dispensing after Surgery.
- Author
-
Neuman MD, Hennessy S, Small DS, Newcomb C, Gaskins L, Brensinger CM, Wijeysundera DN, Bateman BT, and Wunsch H
- Subjects
- Adult, Analgesics, Opioid standards, Drug and Narcotic Control trends, Female, Humans, Hydrocodone standards, Insurance Claim Review trends, Male, Middle Aged, Pain, Postoperative epidemiology, Retrospective Studies, United States epidemiology, Analgesics, Opioid administration & dosage, Controlled Substances standards, Drug Prescriptions standards, Drug and Narcotic Control legislation & jurisprudence, Hydrocodone administration & dosage, Pain, Postoperative prevention & control
- Abstract
Background: In 2014, the U.S. Drug Enforcement Agency reclassified hydrocodone from Schedule III to Schedule II of the Controlled Substances Act, resulting in new restrictions on refills. The authors hypothesized that hydrocodone rescheduling led to decreases in total opioid dispensing within 30 days of surgery and reduced new long-term opioid dispensing among surgical patients., Methods: The authors studied privately insured, opioid-naïve adults undergoing 10 general or orthopedic surgeries between 2011 and 2015. The authors conducted a differences-in-differences analysis that compared overall opioid dispensing before versus after the rescheduling rule for patients treated by surgeons who frequently prescribed hydrocodone before rescheduling (i.e., patients who were functionally exposed to rescheduling's impact) while adjusting for secular trends via a comparison group of patients treated by surgeons who rarely prescribed hydrocodone (i.e., unexposed patients). The primary outcome was any filled opioid prescription between 90 and 180 days after surgery; secondary outcomes included the 30-day refill rate and the amount of opioids dispensed initially and at 30 days postoperatively., Results: The sample included 65,136 patients. The percentage of patients filling a prescription beyond 90 days was similar after versus before rescheduling (absolute risk difference, -1.1%; 95% CI, -2.3% to 0.1%; P = 0.084). The authors estimated the rescheduling rule to be associated with a 45.4-mg oral morphine equivalent increase (difference-in-differences estimate; 95% CI, 34.2-56.7 mg; P < 0.001) in initial opioid dispensing, a 4.1% absolute decrease (95% CI, -5.5% to -2.7%; P < 0.001) in refills within 30 days, and a 37.7-mg oral morphine equivalent increase (95% CI, 20.6-54.8 mg; P = 0.008) in opioids dispensed within 30 days., Conclusions: Among patients treated by surgeons who frequently prescribed hydrocodone before the Drug Enforcement Agency 2014 hydrocodone rescheduling rule, rescheduling did not impact long-term opioid receipt, although it was associated with an increase in opioid dispensing within 30 days of surgery.
- Published
- 2020
- Full Text
- View/download PDF
40. Pain Control in Breast Surgery: Survey of Current Practice and Recommendations for Optimizing Management-American Society of Breast Surgeons Opioid/Pain Control Workgroup.
- Author
-
Rao R, Jackson RS, Rosen B, Brenin D, Cornett W, Fayanju OM, Chen SL, Golesorkhi N, Ludwig K, Ma A, Mautner SK, Sowden M, Wilke L, Wexelman B, Blair S, Gary M, Grobmyer S, Hwang ES, James T, Kapoor NS, Lewis J, Lizarraga I, Miller M, Neuman H, Showalter S, Smith L, and Froman J
- Subjects
- Female, Humans, Mastectomy adverse effects, Nerve Block, Pain Management, Pain Measurement, Societies, Medical, Surgeons, Surveys and Questionnaires, United States, Analgesics, Opioid administration & dosage, Breast Neoplasms surgery, Narcotics administration & dosage, Pain, Postoperative prevention & control, Practice Patterns, Physicians' statistics & numerical data
- Abstract
Introduction: The opioid epidemic in the United States is a public health crisis. Breast surgeons are obligated to provide good pain control for their patients after surgery but also must minimize administration of narcotics to prevent a surgical episode of care from becoming a patient's gateway into opioid dependence., Methods: A survey to ascertain pain management practice patterns after breast surgery was performed. A review of currently available literature that was specific to breast surgery was performed to create recommendations regarding pain management strategies., Results: A total of 609 surgeons completed the survey and demonstrated significant variations in pain management practices, specifically within regards to utilization of regional anesthesia (e.g., nerve blocks), and quantity of prescribed narcotics. There is excellent data to guide the use of local and regional anesthesia. There are, however, fewer studies to guide narcotic recommendations; thus, these recommendations were guided by prevailing practice patterns., Conclusions: Pain management practices after breast surgery have significant variation and represent an opportunity to improve patient safety and quality of care. Multimodality approaches in conjunction with standardized quantities of narcotics are recommended.
- Published
- 2020
- Full Text
- View/download PDF
41. What Happens to Unused Opioids After Total Joint Arthroplasty? An Evaluation of Unused Postoperative Opioid Disposal Practices.
- Author
-
Kunkel ST, Sabatino MJ, Pierce DA, Fillingham YA, Jevsevar DS, and Moschetti WE
- Subjects
- Analgesics, Opioid, Humans, Pain, Postoperative drug therapy, Pain, Postoperative prevention & control, Practice Patterns, Physicians', United States epidemiology, Arthroplasty, Replacement, Hip adverse effects, Arthroplasty, Replacement, Knee adverse effects
- Abstract
Background: This study evaluates the fate of unused opioids after total hip arthroplasty (THA) and total knee arthroplasty (TKA) at our facility., Methods: Medication disposal after primary elective THA and TKA was classified as appropriate (in accordance with United States Food and Drug Administration guidelines) or inappropriate for all patients undergoing these procedures during the second half of the fiscal year 2015., Results: In total, 199 THAs and 144 TKAs met inclusion criteria. Total pills prescribed were 55,635. Approximately 8925 (16%) of pills were unused. About 39.9% of patients disposed of unused opioids appropriately, while 60.1% of patients reported still having (18.5%), not knowing where they were (8.2%), or other (33.4%). There was no significant association with the type of opioid prescribed., Conclusion: A large volume of unused opioids were improperly disposed of after total joint arthroplasty., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
42. Including Patients on Preoperative Opioids in Enhanced Recovery After Surgery Programs and Research: Are We Ready?
- Author
-
Stone AB
- Subjects
- Consensus, Humans, Pain Management, Pain, Postoperative diagnosis, Pain, Postoperative prevention & control, United States, Analgesics, Opioid adverse effects, Enhanced Recovery After Surgery
- Published
- 2020
- Full Text
- View/download PDF
43. Practice Patterns in Perioperative Nonopioid Analgesic Administration by Anesthesiologists in a Veterans Affairs Hospital.
- Author
-
Kwong JZ, Mudumbai SC, Hernandez-Boussard T, Popat RA, and Mariano ER
- Subjects
- Adult, Aged, Aged, 80 and over, Drug Therapy, Combination statistics & numerical data, Female, Hospitals, Humans, Male, Middle Aged, Pain, Postoperative prevention & control, United States, United States Department of Veterans Affairs, Analgesics, Non-Narcotic administration & dosage, Anesthesiologists, Drug Therapy, Combination methods, Pain Management methods, Practice Patterns, Physicians' statistics & numerical data
- Abstract
Objective: Although multimodal analgesia (MMA) is recommended for perioperative pain management, previous studies have found substantial variability in its utilization. To better understand the factors that influence anesthesiologists' choices, we assessed the associations between patient or surgical characteristics and number of nonopioid analgesic modes received intraoperatively across a variety of surgeries in a university-affiliated Veteran Affairs hospital., Methods: We included elective inpatient surgeries (orthopedic, thoracic, spine, abdominal, and pelvic procedures) that used at least one nonopioid analgesic within a one-year period. Multivariable multinomial logistic regression models were used to estimate adjusted odds ratios and 95% confidence intervals (CIs). We also described the combinations of analgesia used in each surgical subtype and conducted exploratory analyses to test the associations between the number of modes used and postoperative outcomes., Results: Of the 1,087 procedures identified, 33%, 53%, and 14% were managed with one, two, and three or more modes, respectively. Older patients had lower odds of receiving three or more modes (adjusted odds ratio [aOR] = 0.28, 95% confidence interval [CI] = 0.15-0.52), as were patients with more comorbidities (two modes: aOR = 0.87, 95% CI = 0.79-0.96; three or more modes: aOR = 0.81, 95% CI = 0.71-0.94). Utilization varied across surgical subtypes P < 0.0001). Increasing the number of modes, particularly use of regional anesthesia, was associated with shorter length of stay., Conclusions: Our study suggests that age, comorbidities, and surgical type contribute to variability in MMA utilization. Risks and benefits of multiple modes should be carefully considered for older and sicker patients. Future directions include developing patient- and procedure-specific perioperative MMA recommendations., (2019 American Academy of Pain Medicine. This work is written by US Government employees and is in the public domain in the US.)
- Published
- 2020
- Full Text
- View/download PDF
44. Anesthesia and Analgesia Practices in Total Joint Arthroplasty: A Survey of the American Association of Hip and Knee Surgeons Membership.
- Author
-
Hannon CP, Keating TC, Lange JK, Ricciardi BF, Waddell BS, and Della Valle CJ
- Subjects
- Adult, Analgesics, Opioid, Humans, Pain, Postoperative drug therapy, Pain, Postoperative epidemiology, Pain, Postoperative prevention & control, Practice Patterns, Physicians', Surveys and Questionnaires, United States, Analgesia, Arthroplasty, Replacement, Hip, Surgeons
- Abstract
Background: The purpose of this study is to survey the current analgesia and anesthesia practices used by total joint arthroplasty surgeon members of the American Association of Hip and Knee Surgeons (AAHKS)., Methods: A survey of 28 questions was created and approved by the AAHKS Research Committee. The survey was distributed to all 2208 board-certified adult reconstruction surgeon members of AAHKS in November 2018., Results: There were 622 responses (28.2%) to the survey. A majority of respondents (93.2%, n = 576) use preemptive analgesia prior to total joint arthroplasty. Most respondents use a spinal for total knee arthroplasty (TKA) (74.4%) and total hip arthroplasty (THA) (72.6%). A peripheral nerve block is routinely used by 68.7% of respondents in primary TKA. Periarticular injection or local infiltration anesthesia is routinely used by 80.3% of respondents for both TKA and THA patients. The average number of opioid pills prescribed postoperatively after TKA is 49 pills (range 0-200) and after THA is 44 pills (range 0-200). Most surgeons (58%) expect that this prescription should last for 2 weeks. A majority of respondents (74.0%) use multimodal analgesics in addition to opioids., Conclusion: There is no consensus regarding the optimal multimodal anesthetic and analgesic regimen for total joint arthroplasty among surveyed board-certified arthroplasty surgeon members of AAHKS. Understanding current practice patterns in anesthesia, analgesia, and opioid prescribing may serve as a platform for future work aimed at establishing best clinical practices of maximizing effective postoperative pain control and minimizing the risks associated with prescribing opioids., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
45. A contemporary medicolegal claims analysis of injuries related to neuraxial anesthesia between 2007 and 2016.
- Author
-
Huang H, Yao D, Saba R, Brovman EY, Kang D, Greenberg P, and Urman RD
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Anesthesia, Epidural economics, Anesthesia, Obstetrical economics, Anesthesia, Spinal adverse effects, Anesthesia, Spinal economics, Benchmarking economics, Benchmarking legislation & jurisprudence, Benchmarking statistics & numerical data, Child, Communication, Databases, Factual statistics & numerical data, Female, Humans, Informed Consent legislation & jurisprudence, Insurance, Liability statistics & numerical data, Male, Malpractice economics, Malpractice legislation & jurisprudence, Middle Aged, Pain, Postoperative etiology, Pain, Postoperative prevention & control, Physician-Patient Relations, Postoperative Complications epidemiology, Postoperative Complications etiology, Postoperative Complications prevention & control, Pregnancy, Radiculopathy epidemiology, Radiculopathy etiology, Radiculopathy prevention & control, Retrospective Studies, Surgical Procedures, Operative adverse effects, United States epidemiology, Young Adult, Anesthesia, Epidural adverse effects, Anesthesia, Obstetrical adverse effects, Insurance Claim Review statistics & numerical data, Malpractice statistics & numerical data, Postoperative Complications economics, Radiculopathy economics
- Abstract
Study Objective: To provide a contemporary medicolegal analysis of claims brought against anesthesia providers in the United States related to neuraxial blocks for surgery and obstetrics., Design: In this retrospective analysis, we analyzed closed claims data from the Controlled Risk Insurance Company (CRICO) Comparative Benchmarking System (CBS) database between 2007 and 2016., Setting: Closed claims from inpatient and outpatient settings related to neuraxial anesthesia for surgical procedures and obstetrics., Patients: Forty-five claims were identified for analysis. These patients underwent a variety of surgical procedures, included both children and adults, and with ages ranging from 6 to 82., Interventions: Patients receiving neuraxial anesthesia (spinals, epidurals) for surgery or obstetrics., Measurements: Data collected includes patient demographics, alleged injury type/severity, surgical specialty, likely contributors to the alleged damaging event, and case outcome. Some of the data were drawn directly from coded variables in the CRICO database, and some were gathered from narrative case summaries., Main Results: Settlement payments were made in 20% of claims. Reported adverse outcomes ranged from temporary minor to permanent major injuries. Most closed claims were classified as permanent minor injuries. The greatest number of claims involved residual weakness and radiculopathy resulting from epidurals. The largest contributing factor to these injuries was noted to be "Technical Knowledge/Performance" of the anesthesia provider followed by "Missing or Documentation Error." Over half of the claims arose from obstetric patients (31%) and patients undergoing orthopedic surgery (27%)., Conclusions: Patients with pre-existing radiculopathy or comorbidities may warrant more thorough informed consent about the increased risk of injury. Additionally, prompt follow-up, monitoring, and documentation of post-operative symptoms, such as weakness or radiculopathy, are crucial for improving patient safety and satisfaction. More timely communication with the patient and the surgical team regarding residual neurologic symptoms is important for earlier diagnosis of injury., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
46. Potential opioid-related adverse events following spine surgery in elderly patients.
- Author
-
Jones MR, Brovman EY, Novitch MB, Rao N, and Urman RD
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Male, Pain, Postoperative etiology, Retrospective Studies, United States epidemiology, Analgesics, Opioid adverse effects, Length of Stay trends, Medicare trends, Pain, Postoperative prevention & control, Spinal Diseases drug therapy, Spinal Diseases surgery
- Abstract
Objective: Understanding the clinical and economic impact of opioid-related adverse drug events (ORADEs) within spine surgery may guide both the clinician's and hospital administration's approach to treating perioperative pain, thus improving patient care and reducing hospital costs. The objective of this analysis is to understand how potential ORADEs after spine surgery in elderly patients affect length of stay, hospital revenue and their association with comorbid conditions., Patients and Methods: We conducted a retrospective study utilizing the Center for Medicare/Medicaid Services Administrative Database to analyze Medicare discharges between April 2016 and March 2017 involving 14 spine surgery DRGs for major spine procedures in order to identify potential ORADEs. An analysis was conducted using this database to identify the incidence of potential ORADEs as well as their impact on mean hospital length of stay and hospital revenue., Results: There were 177,432 discharges during the study period. The ORADE rate in patients undergoing spine surgery was 13.9% (24,642/177,432). The mean length of stay (LOS) for discharges with an ORADE was 3.13 days longer than without an ORADE (6.29 days with an ORADE vs 3.16 days without an ORADE). The adverse post-operative outcomes most strongly associated with potential ORADEs included shock, pneumonia, and septicemia. The mean hospital revenue per day with an ORADE was $3,076 less than without an ORADE ($7,263 with an ORADE vs $10,339 without an ORADE)., Conclusion: Potential ORADEs in spine surgery in elderly patients are common and are associated with longer hospitalizations and decreased hospital revenue. Perioperative pain management strategies that reduce ORADEs may improve patient care and increase hospital revenue., (Copyright © 2019 Elsevier B.V. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
47. Updates on pediatric regional anesthesia safety data.
- Author
-
Vargas A, Sawardekar A, and Suresh S
- Subjects
- Age Factors, Anesthesia, Conduction adverse effects, Anesthesia, Conduction standards, Anesthesiology methods, Anesthesiology standards, Anesthetics, Local adverse effects, Child, Datasets as Topic, Europe, Humans, Pain, Postoperative etiology, Practice Guidelines as Topic, Societies, Medical standards, Treatment Outcome, United States, Anesthesia, Conduction methods, Anesthetics, Local administration & dosage, Pain, Postoperative prevention & control, Surgical Procedures, Operative adverse effects
- Abstract
Purpose of Review: The clinical practice of anesthesia continues to evolve and grow toward increasing quality and safety while improving the patient and family perioperative experience. Within the realm of pediatric anesthesia, advances in regional anesthesia techniques are important part in this aim., Recent Findings: The aim of this review is to provide an update on recent advances in pediatric regional anesthesia. This includes an emphasis on safety data from large datasets that previously were not available. In addition, novel blocks within pediatric regional anesthesia will be described., Summary: Large data sets have given clinical providers information into the practice of regional anesthesia. It has confirmed the safety of common regional anesthetic techniques in addition to providing guidance to improving outcomes for children.
- Published
- 2019
- Full Text
- View/download PDF
48. Opioid Prescribing After Surgery in the United States, Canada, and Sweden.
- Author
-
Ladha KS, Neuman MD, Broms G, Bethell J, Bateman BT, Wijeysundera DN, Bell M, Hallqvist L, Svensson T, Newcomb CW, Brensinger CM, Gaskins LJ, and Wunsch H
- Subjects
- Adult, Arthroscopy, Canada epidemiology, Cholecystectomy, Female, Humans, Laparoscopy, Male, Mammaplasty, Middle Aged, Pain, Postoperative epidemiology, Pain, Postoperative prevention & control, Retrospective Studies, Sweden epidemiology, United States epidemiology, Young Adult, Analgesics, Opioid therapeutic use, Pain, Postoperative drug therapy, Practice Patterns, Physicians' statistics & numerical data
- Abstract
Importance: Small studies and anecdotal evidence suggest marked differences in the use of opioids after surgery internationally; however, this has not been evaluated systematically across populations receiving similar procedures in different countries., Objective: To determine whether there are differences in the frequency, amount, and type of opioids dispensed after surgery among the United States, Canada, and Sweden., Design, Setting, and Participants: This cohort study included patients without previous opioid prescriptions aged 16 to 64 years who underwent 4 low-risk surgical procedures (ie, laparoscopic cholecystectomy, laparoscopic appendectomy, arthroscopic knee meniscectomy, and breast excision) between January 2013 and December 2015 in the United States, between July 2013 and March 2016 in Canada, and between January 2013 and December 2014 in Sweden. Data analysis was conducted in all 3 countries from July 2018 to October 2018., Main Outcomes and Measures: The main outcome was postoperative opioid prescriptions filled within 7 days after discharge; the percentage of patients who filled a prescription, the total morphine milligram equivalent (MME) dose, and type of opioid dispensed were compared., Results: The study sample consisted of 129 379 patients in the United States, 84 653 in Canada, and 9802 in Sweden. Overall, 52 427 patients (40.5%) in the United States were men, with a mean (SD) age of 45.1 (12.7) years; in Canada, 25 074 patients (29.6%) were men, with a mean (SD) age of 43.5 (13.0) years; and in Sweden, 3314 (33.8%) were men, with a mean (SD) age of 42.5 (13.0). The proportion of patients in Sweden who filled an opioid prescription within the first 7 days after discharge for any procedure was lower than patients treated in the United States and Canada (Sweden, 1086 [11.1%]; United States, 98 594 [76.2%]; Canada, 66 544 [78.6%]; P < .001). For patients who filled a prescription, the mean (SD) MME dispensed within 7 days of discharge was highest in United States (247 [145] MME vs 169 [93] MME in Canada and 197 [191] MME in Sweden). Codeine and tramadol were more commonly dispensed in Canada (codeine, 26 136 patients [39.3%]; tramadol, 12 285 patients [18.5%]) and Sweden (codeine, 170 patients [15.7%]; tramadol, 315 patients [29.0%]) than in the United States (codeine, 3210 patients [3.3%]; tramadol, 3425 patients [3.5%])., Conclusions and Relevance: The findings indicate that the United States and Canada have a 7-fold higher rate of opioid prescriptions filled in the immediate postoperative period compared with Sweden. Of the 3 countries examined, the mean dose of opioids for most surgical procedures was highest in the United States.
- Published
- 2019
- Full Text
- View/download PDF
49. The Opioid Crisis: The Surgeon's Role.
- Author
-
Goldberg RF
- Subjects
- Analgesics, Opioid, Education, Medical, Continuing, Health Policy, History, 20th Century, History, 21st Century, Humans, Opioid Epidemic history, Opioid Epidemic statistics & numerical data, Opioid-Related Disorders epidemiology, Pain, Postoperative prevention & control, Patient Education as Topic, Prescription Drug Misuse legislation & jurisprudence, United States epidemiology, Opioid Epidemic prevention & control, Opioid-Related Disorders prevention & control, Physician's Role, Surgeons education
- Published
- 2019
- Full Text
- View/download PDF
50. Use of perioperative epidural analgesia among Medicare patients undergoing hepatic and pancreatic surgery.
- Author
-
Merath K, Hyer JM, Mehta R, Bagante F, Paredes A, Wu L, Sahara K, Dillhoff M, Cloyd J, Ejaz A, Tsung A, and Pawlik TM
- Subjects
- Aged, Aged, 80 and over, Analgesia, Epidural economics, Cohort Studies, Databases, Factual, Female, Humans, Length of Stay, Male, Pain Measurement, Perioperative Care economics, Perioperative Care methods, Prognosis, Retrospective Studies, Risk Assessment, Treatment Outcome, United States, Analgesia, Epidural methods, Hepatectomy methods, Hospital Costs, Medicare economics, Pain, Postoperative prevention & control, Pancreatectomy methods
- Abstract
Background: We sought to characterize epidural analgesia (EA) use among Medicare patients undergoing hepatopancreatic (HP) procedures, identify factors associated with EA use and asses perioperative outcomes., Methods: Patients undergoing HP surgery were identified using the Inpatient Standard Analytic Files. Logistic regression was utilized to identify factors associated with EA receipt, and assess associations of EA with in-hospital outcomes and Medicare expenditures., Results: Among 20,562 patients included in the study, 6.7% (n =1362) had EA. There was no difference in the odds of complications (OR 1.05, 95% CI 0.93-1.19) or blood transfusions (OR 0.90, 95% CI 0.79-1.03) with EA versus conventional analgesia (CA). The odds of prolonged LOS (OR 1.16, 95% CI 1.03-1.30) were higher with EA; the odds of in-hospital mortality were higher with conventional analgesia (OR 1.90, 95% CI 1.28-2.83). Medicare payments for liver surgery were comparable among EA ($19,500) versus conventional analgesia ($19,300, p = 0.85) and slightly higher for EA ($23,600) versus conventional analgesia ($22,000, p < 0.001) for pancreatic procedures., Conclusion: EA utilization among Medicare patients undergoing HP was low. While EA was not associated with morbidity, it resulted in an average additional one day LOS and slightly higher expenditures in pancreatic surgery., (Copyright © 2019 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.